West Virginia Code of State Rules › Agency 11 - Medicine › Title 11 - LEGISLATIVE RULE WEST VIRGINIA BOARD OF MEDICINE › Series 11-01B - Licensure, Practice Requirements, Disciplinary and Complaint Procedures, Continuing Education, Physician Assistants › Section 11-1B-2 - Definitions

Current through Register Vol. XLI, No. 28, July 12, 2024
2.1. "Active
				practice notification" means a practice notification which is currently in
				effect.
2.2. "Authorization to
				practice" means written notification from the Board that a physician assistant
				may commence practice in collaboration with physicians pursuant to an active
				practice notification.
2.3. "Board"
				means the West Virginia Board of Medicine.
2.4. "Collaborating Physician" means a doctor
				of medicine, osteopathic medicine, or podiatric medicine fully authorized to
				practice clinical medicine or podiatric medicine in West Virginia by the
				appropriate board in this state without restriction or limitation, who
				collaborates with physician assistants.
2.5. "Collaboration" means overseeing the
				activities of the medical services rendered by a physician assistant. Constant
				physical presence of the collaborating physician is not required as long as the
				collaborating physician and physician assistant are, or can be, easily in
				contact with one another by telecommunication. Collaboration does not require
				the personal presence of the collaborating physician at the place or places
				where services are rendered.
2.6.
				"Controlled substances" means drugs that are classified by federal or state law
				in Schedules I, II, III, IV or V, as defined in W. Va. Code Chapter 60A,
				Article 2.
2.7. "Core duties" means
				medical acts that are included in the standard curricula of accredited
				physician assistant education programs.
2.8. "Endorsement" means a summer camp or
				volunteer endorsement to practice as a physician assistant as set forth in W.
				Va. Code §
									30-3E-1
et
				seq
.
2.9. "Health care
				facility" means any licensed hospital, nursing home, extended care facility,
				state health or mental institution, clinic or physician's office.
2.10. "Hospital" means a facility licensed
				pursuant to W. Va. Code §
									16-5B-1
et
				seq
.
2.11. "License" means
				a license issued by the Board to a physician assistant applicant pursuant to
				the provisions of W. Va. Code §
									30-3E-1
et
				seq
.
2.12. "Licensee"
				means a physician assistant licensed pursuant to the provisions of W. Va. Code
				§
									30-3E-1
et seq
.
				and the provisions of this legislative rule.
2.13. "Licensure" means the process of
				application to the Board, and the Board's consideration and approval of
				individuals to practice as physician assistants in collaboration with
				physicians.
2.14. "Narcotic drug"
				and "opioid" mean controlled substance medications which are natural and
				semi-synthetic derivatives of the opium poppy, as well as similar synthetic
				compounds that have analgesic or pain relieving properties because of their
				effects in the central nervous system. Narcotics and opioids include, but are
				not limited to, codeine, morphine, hydromorphone, hydrocodone, oxycodone,
				methadone, and fentanyl.
2.15.
				"NCCPA" means The National Commission on the Certification of Physician
				Assistants.
2.16. "Osteopathic
				Board" means the West Virginia Board of Osteopathic Medicine.
2.17. "Physician" means a doctor of
				allopathic or osteopathic medicine who is fully licensed by the Board or the
				Osteopathic Board to practice medicine or surgery in this state.
2.18. "Physician Assistant" means a person
				who meets the qualifications set forth in the Physician Assistants Practice
				Act, W. Va. Code §
									30-3E-1
et seq
.,
				and is licensed to practice medicine with a collaborating physician or
				podiatric physician. Physician assistant also means an individual who holds a
				physician assistant license in another state and an interstate telehealth
				registration issued by this Board.
2.19. "Podiatric physician" means a physician
				of podiatric medicine who is fully licensed by the Board to practice podiatric
				medicine in this state.
2.20.
				"Practice notification" means a written notice to the Board that a physician
				assistant will practice in collaboration with one or more physicians in the
				state of West Virginia.
2.21.
				"Practice setting" means the type of practice environment, and includes
				hospitals, ambulatory surgical facilities, clinics, private medical offices,
				and long term care facilities.
2.22. "Prescription drug" means a drug that
				may be dispensed under federal or state law only pursuant to the prescription
				of an authorized prescriber.
2.23.
				"Prescriptive authority" means the authority of a physician assistant to
				prescribe, order, administer or dispense prescription drugs.
2.24. "Registrant" means a physician
				assistant issued an interstate telehealth registration by the Board pursuant to
				W. Va. Code §
									30-1-26.
2.25. "Registration" means an authorization
				to practice in collaboration with physicians issued by the Board pursuant to W.
				Va. Code §
									30-1-26 for the limited purpose of
				providing interstate telehealth services.
2.26. "Reporting period" means the two-year
				period preceding the renewal deadline for a license issued by the Board.
				Continuing education satisfactory to the Board must be obtained in each
				reporting period.
2.27. "Risk
				Assessment and Responsible Prescribing of Controlled Substances" means drug
				diversion training, best-practice prescribing of controlled substances
				training, and training on prescribing and administering an opioid antagonist
				which includes all of the following components:
2.27.1. Risk Assessment and responding to
				drug diversion and drug seeking behavior including:
2.27.1.a. Tools for conducting routine
				patient assessments for risk factors associated with drug diversion, misuse or
				abuse and identification of substance use disorder treatment referral
				resources;
2.27.1.b. West Virginia
				statistics on prescription drug abuse and resulting deaths;
2.27.1.c. Identification of diversion and
				drug seeking tactics and behaviors;
2.27.1.d. Best practices for assessing,
				treating and referring patients suspected of drug seeking behavior, diversion
				or substance use disorder;
2.27.1.e. Introduction to Medication for
				Opioid Use Disorder (MOUD) and training on the effectiveness of MOUD treatment
				including the use of full opioid agonist, partial opioid agonist, and opioid
				antagonists; and
2.27.1.f. Training
				on the impacts of stigma on treatment effectiveness including the concept of
				addiction as a chronic disease.